Third-Line Chemotherapy for Metastatic Urothelial Cancer: A Retrospective Observational Study

The prognosis of locally advanced (T3/T4 or N1) and metastatic disease urothelial carcinoma is poor. In this retrospective study, we reviewed data about patients receiving third-line chemotherapy for metastatic disease, in view of the lack of data in this setting. We retrospectively analyzed medical...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Lorenzo, Giuseppe, Buonerba, Carlo, Bellelli, Teresa, Romano, Concetta, Montanaro, Vittorino, Ferro, Matteo, Benincasa, Alfonso, Ribera, Dario, Lucarelli, Giuseppe, De Cobelli, Ottavio, Sonpavde, Guru, De Placido, Sabino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
7300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697979/
https://www.ncbi.nlm.nih.gov/pubmed/26705213
http://dx.doi.org/10.1097/MD.0000000000002297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697979/
https://www.ncbi.nlm.nih.gov/pubmed/26705213
http://dx.doi.org/10.1097/MD.0000000000002297

Ejemplares similares